Rare malignant tumors of the breast

被引:0
|
作者
Pervan, Mascha [1 ,2 ]
Princk, Henriette [1 ,2 ]
Meneder, Sabine [1 ]
Banys-Paluchowski, Maggie [1 ]
Fehm, Tanja [3 ]
Ruckhaeberle, Eugen [3 ]
Hanker, Lars [1 ]
Fitzgerald, Sophia [1 ]
Rody, Achim [1 ]
Krawczyk, Natalia [3 ,4 ]
机构
[1] Univ Klinikum Schleswig Holstein, Klin Gynakol & Geburtshilfe, Campus Lubeck, Lubeck, Germany
[2] Univ Canc Ctr Schleswig Holstein UCCSH, Campus Lubeck, Lubeck, Germany
[3] Univ Klin Dusseldorf, Klin Frauenheilkunde & Geburtshilfe, Dusseldorf, Germany
[4] Univ Klin Dusseldorf, Klin Frauenheilkunde & Geburtshilfe, Moorenstr 5, D-40225 Dusseldorf, Germany
来源
GYNAKOLOGIE | 2024年 / 57卷 / 01期
关键词
Metaplastic breast cancer; Neuroendocrine breast cancer; Adenoid cystic carcinoma; Cystosarcoma phyllodes; Breast sarcoma; LARGE-CELL LYMPHOMA; INVASIVE NEUROENDOCRINE CARCINOMA; CANCER; THERAPY; MANAGEMENT;
D O I
10.1007/s00129-023-05176-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Histologisch findet sich in uber 90 % der invasiven Mammakarzinome entweder eine duktale (NST, ,,no special type") oder eine lobulare Genese. Daruber hinaus existieren seltene Malignome der Brust, darunter Tumoren mesenchymaler, fibroepithelialer oder lymphatischer atiologie, und spezielle Karzinomarten. Diese heterogene Gruppe ist gekennzeichnet durch unterschiedliche klinische Erscheinungsformen und individuelle Biologie, die ein spezifisches, onkologisches Management erfordern. Vorgestellt werden die Besonderheiten der seltenen Malignome der Brust.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 50 条
  • [21] Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast
    Park, Hae Jin
    Ryu, Han Suk
    Kim, Kyubo
    Shin, Kyung Hwan
    Han, Wonshik
    Noh, Dong-Young
    IN VIVO, 2019, 33 (01): : 263 - 269
  • [22] Malignant tumors of the heart
    Hudzik, Bartosz
    Miszalski-Jamka, Karol
    Glowacki, Jan
    Lekston, Andrzej
    Gierlotka, Marek
    Zembala, Marian
    Polonski, Lech
    Gasior, Mariusz
    CANCER EPIDEMIOLOGY, 2015, 39 (05) : 665 - 672
  • [23] The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases
    Wojcinski, S.
    Stefanidou, N.
    Hillemanns, P.
    Degenhardt, F.
    BMC WOMENS HEALTH, 2013, 13
  • [24] Clinical and molecular epidemiology of malignant salivary gland tumors
    Jansen, Louis
    Nachtsheim, Lisa
    Mayer, Marcel
    Arolt, Christoph
    Quaas, Alexander
    Klussmann, Jens Peter
    Wolber, Philipp
    LARYNGO-RHINO-OTOLOGIE, 2025, 104 (02) : 87 - 93
  • [25] Metastatic and Malignant Phyllodes Tumors of the Breast: An Update for Current Management
    Goodwin, Brandon
    Oyinlola, Adejumoke Fisayo
    Palhang, Meejan
    Lehman, Danielle
    Platoff, Rebecca
    Atabek, Umur
    Spitz, Francis
    Hong, Young
    AMERICAN SURGEON, 2023, 89 (12) : 6190 - 6196
  • [26] Malignant Spindle Cell Tumors of the Breast: A Guide for the Practicing Pathologist
    Bode-Omoleye, Olaoluwa
    Arora, Komal
    Yeh, I-Tien
    AJSP-Reviews and Reports, 2016, 21 (01): : 16 - 23
  • [27] Unusual malignant tumors of the breast: MRI features and pathologic correlation
    Linda, Anna
    Zuiani, Chiara
    Girometti, Rossano
    Londero, Viviana
    Machin, Piernicola
    Brondani, Giovanni
    Bazzocchi, Massimo
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (02) : 178 - 184
  • [28] THE DESCRIPTIVE EPIDEMIOLOGY OF MALIGNANT CYSTOSARCOMA-PHYLLODES TUMORS OF THE BREAST
    BERNSTEIN, L
    DEAPEN, D
    ROSS, RK
    CANCER, 1993, 71 (10) : 3020 - 3024
  • [29] The impact of adjuvant radiotherapy on Borderline and Malignant Phyllodes Tumors of The Breast
    Charoenyothakun, Amonthep
    Shotelersuk, Kanjana
    Nantavithya, Chonnipa
    Saksornchai, Kitwadee
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S473 - S478
  • [30] Management of malignant phyllodes tumors of the breast: The experience of the Institut Curie
    Haberer, S.
    Lae, M.
    Seegers, V.
    Pierga, J. -Y.
    Salmon, R.
    Kirova, Y. M.
    Dendale, R.
    Campana, F.
    Reyal, F.
    Miranda, O.
    Fourquet, A.
    Bollet, M. -A.
    CANCER RADIOTHERAPIE, 2009, 13 (04): : 305 - 312